TrialThe Journal of clinical endocrinology and metabolism2015

A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.

Ashwini Mallappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.